What We Make
High - Quality Tools Life Scientists Use to Seek Answers
Reagent " Tool Kits"
Specific combinations of chemistries that allow customers to carry out laboratory tests in the fields of cell biology; DNA, RNA and protein analysis; drug development; human identification; and molecular diagnostics.
Integrated Systems
Instrumentation that allows customers to automate their various research and lab procedures, increasing efficiency and precision.
Where Our Products Are Used
Pharmaceutical and Biotechnology Industries
Discovering new drugs to fight disease
Clinical and Molecular Diagnostics Laboratories
Detecting disease and determining therapies
Forensics and Paternity Laboratories
Discovering new drugs to fight disease
Government and Academic Research Laboratories
Discovering new drugs to fight disease
Applied Testing
Ensuring environmental food, water and plant safety and quality
Our Living Values
We have a 100 year mindset to keep asking questions that change the world. Promega exists on an evolutionary frontier where the values of science, business and human well-being intersect.
Read more about our purpose and values.
Integrated Systems
Instrumentation that allows customers to automate their various research and lab procedures, increasing efficiency and precision.
American Ginseng Suppresses Colitis through p53-Mediated Apoptosis of Inflammatory Cells
+Author Affiliations
Lorne J. Hofseth, Department of Biomedical and Pharmaceutical Sciences, South Carolina College of Pharmacy, 770 Sumter Street, Coker Life Sciences, Room 513C, University of South Carolina, Columbia, SC 29208. Phone: 803-777-6627/2080; Fax: 803-777-8356; E-mail: hofseth@cop.sc.edu.
Abstract
Ulcerative colitis is a dynamic, chronic inflammatory condition associated with an increased colon cancer risk. Inflammatory cell apoptosis is a key mechanism regulating ulcerative colitis. American ginseng (AG) is a putative antioxidant that can suppress hyperactive immune cells. We have recently shown that AG can prevent and treat mouse colitis. Because p53 levels are elevated in inflammatory cells in both mouse and human colitis, we tested the hypothesis that AG protects from colitis by driving inflammatory cell apoptosis through a p53 mechanism. We used isogenic p53+/+ and p53−/− inflammatory cell lines as well as primary CD4+/CD25− effector T cells from p53+/+ and p53−/− mice to show that AG drives apoptosis in a p53-dependent manner. Moreover, we used a dextran sulfate sodium (DSS) model of colitis in C57BL/6 p53+/+ and p53−/− mice to test whether the protective effect of AG against colitis is p53 dependent. Data indicate that AG induces apoptosis in p53+/+ but not in isogenic p53−/− cells in vitro. In vivo, C57BL/6 p53+/+ mice are responsive to the protective effects of AG against DSS-induced colitis, whereas AG fails to protect from colitis in p53−/− mice. Furthermore, terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling of inflammatory cells within the colonic mesenteric lymph nodes is elevated in p53+/+ mice consuming DSS + AG but not in p53−/− mice consuming DSS + AG. Results are consistent with our in vitro data and with the hypothesis that AG drives inflammatory cell apoptosis in vivo, providing a mechanism by which AG protects from colitis in this DSS mouse model. Cancer Prev Res; 3(3); 339–47